Jason Laine

CBD Oil for Anxiety: Promise, Limits and Precautions 0
- CANNABIS OIL
- February 4, 2026
Cannabidiol (CBD) oil is emerging as a potential tool for managing anxiety, but experts caution that the evidence remains incomplete and uneven. Recent reviews suggest CBD may ease symptoms in conditions such as generalized and seasonal affective anxiety disorders, with clearer benefits at daily doses in the 300–400 milligram range, though responses vary widely between
READ MORE
Cannabis Reform in Flux: 2026 Brings Fresh Uncertainty to U.S. Weed Laws 0
- MEDICAL MARIJUANA
- January 30, 2026
As President Donald Trump’s 2025 executive order to reschedule cannabis moves forward, America’s $32 billion marijuana industry faces both promise and peril. The order directs the Attorney General to downgrade marijuana from a Schedule I to Schedule III substance—an administrative shift that could unlock major tax relief but still fall short of full legalization. Meanwhile,
READ MORE

Cannabis May Rival Lorazepam for Treating Insomnia, Thai Study Finds 0
- CANNABIS OIL
- January 27, 2026
A new clinical trial out of Thailand suggests that cannabis-based treatments may be just as effective as lorazepam, a commonly prescribed benzodiazepine, for managing chronic insomnia. Published in Sleep Medicine, the randomized trial involved 60 adults who received either lorazepam, cannabis oil extracts, or a cannabinoid-infused herbal pill nightly for four weeks. All three groups
READ MORE
Hawaiʻi Dispensary Owners Urge Action on Cannabis Legalization 0
- MEDICAL MARIJUANA
- January 20, 2026
Hawaiʻi could soon join the growing list of states allowing recreational cannabis, as a proposed constitutional amendment by Rep. David Tarnas may put the issue before voters this November. Currently operating under a medical-only framework, dispensary owners say the state’s system no longer reflects modern realities. TY Cheng of Aloha Green Apothecary criticized lawmakers for
READ MORE